4//SEC Filing
DEC TIMOTHY C 4
Accession 0001628280-25-011984
CIK 0001356576other
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 4:15 PM ET
Size
14.0 KB
Accession
0001628280-25-011984
Insider Transaction Report
Form 4
DEC TIMOTHY C
Senior Vice-President & CFO
Transactions
- Tax Payment
Common Stock
2025-03-10$32.06/sh−1,062$34,048→ 11,836 total - Exercise/Conversion
Common Stock
2025-03-10+1,800→ 13,636 total - Tax Payment
Common Stock
2025-03-10$32.06/sh−955$30,617→ 12,681 total - Exercise/Conversion
Performance Share Unit
2025-03-10−2,000→ 0 totalExercise: $0.00→ Common Stock (2,000 underlying) - Exercise/Conversion
Performance Share Unit
2025-03-10−1,800→ 0 totalExercise: $0.00→ Common Stock (1,800 underlying) - Exercise/Conversion
Common Stock
2025-03-10+2,000→ 12,898 total
Footnotes (5)
- [F1]Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 23, 2023.
- [F2]Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units.
- [F3]Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 22, 2024.
- [F4]On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023.
- [F5]On February 22, 2024, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024.
Documents
Issuer
SUPERNUS PHARMACEUTICALS, INC.
CIK 0001356576
Entity typeother
Related Parties
1- filerCIK 0001194020
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 8:00 PM ET
- Accepted
- Mar 11, 4:15 PM ET
- Size
- 14.0 KB